Connect Sign In
The MenoCheck test helps providers treat women who are experiencing menopausal transition and manage the health risks associated with decreased estrogen production.
ARUP’s new lupus anticoagulant panel neutralizes several interfering anticoagulants to limit their impact on test results and reduce the likelihood of false-negative and false-positive results.
ARUP medical directors and scientists will discuss the latest in pharmacogenomics, RNA sequencing, and laboratory genetics career pathways at the upcoming ACMG Annual Clinical Genetics Meeting.
Researchers at ARUP Laboratories published more than 130 peer-reviewed articles and contributed more than 135 posters or presentations at medical conferences in FY2023 to advance laboratory medicine.
Four different algorithms to lead clinicians through the correct approach to thyroid testing are available on arupconsult.com.
Lab testing is key to thyroid disease diagnosis and proper treatment but can be challenging. ARUP Consult’s thyroid disease testing resources are divided into easy-to-navigate topics and algorithms.
After wrapping up her education in plant biology, Dipanwita Banerjee, MS, took some time off to see the world and start a family. She later returned to the laboratory environment at ARUP.
Scammers posing as ARUP recruiters on LinkedIn have attempted to collect sensitive information from job seekers. ARUP recommends that potential applicants approach job offers with caution.
Next generation sequencing provides a more rigorous and sensitive method to identify drug-resistant variants of cytomegalovirus, which enables earlier detection and more effective treatment.
More than 250 ARUP employees participated in Advanced Instruments’ Pipetting Challenge this year. Seven ARUP teams finished in the top 10 in the nationwide competition.
PhD scientists, analysts, and medical directors within ARUP’s Hematopathology department meet often to ensure clinicians and patients receive a diagnosis that reflects an integrated approach.
Days before the public comment period ends, ARUP Laboratories’ experts host webinar to educate and encourage attendees to provide comments on the FDA’s proposed rule to regulate lab-developed tests.
ARUP experts seek to increase understanding of the FDA’s proposed rule to regulate lab-developed tests as medical devices and the impact on hospitals and patients during a webinar on November 29.
